Product Information
EPINASTINE HCL 0.05% EYE DROPS is a generic product labeled by Somerset Therapeutics, LLC, priced at $14.3295 per ML under NDC 70069000801. Its NADAC has been published 504 times since Feb 8, 2017.
FDA first approved this application on Oct 31, 2011.
Strength
.5 mg/mL
Manufacturer
Somerset Therapeutics, LLCNDC
70069000801
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
EPINASTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090951FDA Approved
10/31/2011
On Market Since
9/14/2016
Pharmacological Classes
Price Statistics
The NADAC for EPINASTINE HCL 0.05% EYE DROPS has been published 504 times since Feb 8, 2017, and over the history we have for it it has risen 81.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.3295 per ML |
|---|---|
| All-time high | $16.1864 (Mar 16, 2022) |
| All-time low | $5.6719 (Mar 18, 2020) |
| 52-week high | $15.1838 |
| 52-week low | $12.5207 |
| Median price | $8.1787 |
| Average price | $10.3002 |
| Largest weekly change | +95.1% (Dec 22, 2021) |
| Weeks tracked | 504 |
| Tracking since | Feb 8, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the EPINASTINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
EPINASTINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EPINASTINE HCL 0.05% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for EPINASTINE HCL 0.05% EYE DROPS, manufactured by Somerset Therapeutics, LLC, is $14.3295 per ML (NDC 70069000801), effective Sep 30, 2026.
How has the price of EPINASTINE HCL 0.05% EYE DROPS changed over time?
Over the history we have for it, the NADAC for EPINASTINE HCL 0.05% EYE DROPS has risen 81.2%. It has been tracked across 504 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for EPINASTINE HCL 0.05% EYE DROPS?
Since Feb 8, 2017, the NADAC for EPINASTINE HCL 0.05% EYE DROPS has ranged from a low of $5.6719 (Mar 18, 2020) to a high of $16.1864 (Mar 16, 2022), with a median of $8.1787 per ML.
Are there cheaper alternatives to EPINASTINE HCL 0.05% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of EPINASTINE HCL 0.05% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EPINASTINE HCL 0.05% EYE DROPS?
EPINASTINE HCL 0.05% EYE DROPS (NDC 70069000801) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.